Skip to main content

Advertisement

Log in

Toll-like receptor 4/nuclear factor-κB signaling pathway is involved in ACTG-toxin H-mediated anti-inflammatory effect

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

ACTG-toxin H (AH) originates from Alternaria sp. In this study, we explored the molecular mechanism underlying the anti-inflammatory properties of AH. Treatment with AH inhibited lipopolysaccharide (LPS)-induced interleukin-6, IL-1β, inducible nitric oxide synthase, and cyclooxygenase-2 expression and nitric oxide production. Furthermore, AH inhibited LPS-induced P38 MAPK and Akt activation in RAW264.7 cells. Electrophoretic mobility shift assays (EMSAs) showed that AH inhibited LPS-induced nuclear factor-κB (NFκB) DNA-binding activity. Using transfection assay and measurement of an NFκB-sensitive promoter region, we found that transfection of toll-like receptor 4 (TLR4) increased LPS-induced NFκB transcription activity in 293T cells. AH significantly blocked LPS-induced NFκB activation in TLR4-transfected cells. Taken together, our data indicated that anti-inflammatory properties of AH resulted from the inhibition of proinflammatory cytokines and enzyme production via the TLR4/NFκB signaling pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Qiao LR, Yuan L, Gao JM, Zhao PJ, Kang QJ, Shen YM (2007) Tricycloalternarene derivatives produced by an endophyte Alternaria alternata isolated from Maytenus hookeri. J Basic Microbiol 47:340–343

    Article  PubMed  CAS  Google Scholar 

  2. Murakami A, Ohigashi H (2007) Targeting NOX INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer 121:2357–2363

    Article  PubMed  CAS  Google Scholar 

  3. Payne CM, Bernstein C, Bernstein H, Gerner EW, Garewal H (1999) Reactive nitrogen species in colon carcinogenesis. Antioxid Redox Signal 1:449–467

    Article  PubMed  CAS  Google Scholar 

  4. Park JY, Pillinger MH, Pillinger MH, Abramson SB (2006) Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin Immunol 119:229–240

    Article  PubMed  CAS  Google Scholar 

  5. Nishimoto N, Kishimoto T (2004) Inhibition of IL-6 for the treatment of inflammatory diseases. Curr Opin Pharmacol 4:386–391

    Article  PubMed  CAS  Google Scholar 

  6. Kawai T, Akira S (2006) TLR signaling. Cell Death Differ 13:816–825

    Article  PubMed  CAS  Google Scholar 

  7. Carmody RJ, Chen YH (2007) Nuclear factor-κB: activation and regulation during toll-like receptor signaling. Cell Mol Immunol 4:31–41

    PubMed  CAS  Google Scholar 

  8. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S (1999) Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11:443–451

    Article  PubMed  CAS  Google Scholar 

  9. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Goldenbock DT, Finberg RW (2003) Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2. J Virol 77:4588–4596

    Article  PubMed  CAS  Google Scholar 

  10. Pasare C, Medzhitov R (2004) Toll-like receptors: linking innate and adaptive immunity. Microbes Infect 6:1382–1387

    Article  PubMed  CAS  Google Scholar 

  11. Brown KL, Cosseau CL, Gardy JL, Hancock REW (2007) Complexities of targeting innate immunity to treat infection. Trends Immunol 28:6–206

    Google Scholar 

  12. Lu YC, Yeh WC, Ohashi PS (2008) LPS/TLR4 signal transduction pathway. Cytokine 42:145–151

    Article  PubMed  CAS  Google Scholar 

  13. Kaminska B (2005) MAPK signaling pathways as molecular targets for anti-inflammatory therapy—from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta 1754:253–262

    Article  PubMed  CAS  Google Scholar 

  14. Shao DZ, Lin M (2008) Platonin inhibits LPS-induced NF-kappa B by preventing activation of Akt and IKK-beta in human PBMC. Inflamm Res 57:601–606

    Article  PubMed  CAS  Google Scholar 

  15. Yang XY, Du L, Tang XL, Jung SY, Zheng B, Soh BY (2009) Brevicompanine E reduces lipopolysaccharide-induced production of proinflammatory cytokines and enzymes in microglia by inhibiting activation of activator protein-1 and nuclear factor-κB. J Neuroimmunol 216:32–38

    Article  PubMed  CAS  Google Scholar 

  16. Hoffmann A, Natoli G, Ghosh G (2006) Transcriptional regulation via the NFκB signaling module. Oncogene 25:6706–6716

    Article  PubMed  CAS  Google Scholar 

  17. Billack B (2006) Macrophage activation: role of toll-like receptors, nitric oxide, and nuclear factor kappa B. Am J Pharm Educ 70:102

    Article  PubMed  Google Scholar 

  18. Hobbs AJ, Higgs A, Moncada S (1999) Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol 39:191–220

    Article  PubMed  CAS  Google Scholar 

  19. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA (1996) Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 97:2672–2679

    Article  PubMed  CAS  Google Scholar 

  20. Willoughby DA, Moore AR, Colville-Nash PR (2000) COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet 355:646–648

    Article  PubMed  CAS  Google Scholar 

  21. Turini ME, DuBois RN (2002) Cyclooxygenase-2: a therapeutic target. Annu Rev Med 53:35–57

    Article  PubMed  CAS  Google Scholar 

  22. Palin K, Verrier D, Tridon V, Hurst J, Perry VH, Dantzer R, Lestage J (2004) Influence of the course of brain inflammation on the endogenous IL-1beta/IL-1Ra balance in the model of brain delayed-type hypersensitivity response to bacillus Calmette–Guérin in Lewis rats. J Neuroimmunol 149:22–30

    Article  PubMed  CAS  Google Scholar 

  23. Liang B, Song Z, Wu B, Gardner D, Shealy D, Song XY, Wooley PH (2009) Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis. J Inflamm 6:10

    Article  Google Scholar 

  24. Novotny NM, Markel TA, Crisostomo PR, Meldrum DR (2008) Differential IL-6 and VEGF secretion in adult and neonatal mesenchymal stem cells: role of NFκB. Cytokine 43:215–219

    Article  PubMed  CAS  Google Scholar 

  25. Han J, Lee JD, Bibbs L, Ulevitch RJ (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808–811

    Article  PubMed  CAS  Google Scholar 

  26. Nick JA, Avdi NJ, Gerwins P, Johnson GL, Worthen GS (1996) Activation of a p38 mitogen-activated protein kinase in human neutrophils by lipopolysaccharide. J Immunol 156:4867–4875

    PubMed  CAS  Google Scholar 

  27. Rafi MM, Yadav PN, Rossi AO (2007) Glucosamine inhibits LPS-induced COX-2 and iNOS expression in mouse macrophage cells (RAW264.7) by inhibition of p38-MAP kinase and transcription factor NF-kappa B. Mol Nutr Food Res 51:587–593

    Article  PubMed  CAS  Google Scholar 

  28. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB (1999) NF-kappaB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 401:82–85

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The research was supported by the Public Welfare & Safety Research Program through the National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology (20120006545); the Chinese National Natural Science Fund (30973627); and a grant from Shandong Province of China (No. ZR2009CZ016).

Conflict of interest

The authors have declared that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Qianqun Gu or Hyun Park.

Additional information

The authors Xinying Yang, Guojian Zhang, and Xuelian Tang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, X., Zhang, G., Tang, X. et al. Toll-like receptor 4/nuclear factor-κB signaling pathway is involved in ACTG-toxin H-mediated anti-inflammatory effect. Mol Cell Biochem 374, 29–36 (2013). https://doi.org/10.1007/s11010-012-1502-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-012-1502-9

Keywords

Navigation